Evidence map›Paper›PMID 23700535›Full record

ArticleAdipocyte2012

Role of adipose and hepatic atypical protein kinase C lambda (PKCλ) in the development of obesity and glucose intolerance.

Kirk M Habegger, Daniela Matzke, Nickki Ottaway, Jazzminn Hembree, Jenna Holland, Christine Raver, Johannes Mansfeld, Timo D Müller, Diego Perez-Tilve, Paul T Pfluger and 6 more

Open access · goldAbstract read
In one paragraph

Article in Adipocyte, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 6 countries.

Kirk M HabeggerDivision of Endocrinology; Department of Internal Medicine; Obesity Research Center; Metabolic Diseases Institute; University of Cincinnati; Cincinnati, OH USA.
Daniela Matzke
Nickki Ottaway
Jazzminn Hembree
Jenna Holland
Christine Raver
Johannes Mansfeld
Timo D Müller
Diego Perez-Tilve
Paul T Pfluger
Sang Jun Lee
Maria Diaz-Meco
Jorge Moscat
Michael Leitges
Matthias H Tschöp
Susanna M Hofmann
Oncology Hematology Care · USHelmholtz Zentrum München · DEInfectious Diseases Institute · UGUniversity of Cincinnati · USCanadian Obesity Network · CADiabetes Australia · AUFriedrich Schiller University Jena · DEGerman Institute of Human Nutrition · DEUniversity of Oslo · NO

Funding

Training Program in Cancer TherapeuticsT32CA117846 · NCI · UNIVERSITY OF CINCINNATI · PI PRICE, CAROLYN M, TAKIAR, VINITA · 2006 to 2022
$6.5M
The Par-4/PKCz complex in prostate cancerR01CA134530 · NCI · UNIVERSITY OF CINCINNATI · PI DIAZ MECO CONDE, MARIA TERESA · 2009 to 2013
$1.8M
Neuroendocrine Regulation of Adipocyte MetabolismR01DK077975 · NIDDK · UNIVERSITY OF CINCINNATI · PI PEREZ-TILVE, DIEGO · 2009 to 2013
$1.7M
NCI NIH HHS R01 CA134530NCI NIH HHS T32 CA117846NIDDK NIH HHS R01 DK077975
6 · The paper itself

Abstract

PKCλ, an atypical member of the multifunctional protein kinase C family, has been implicated in the regulation of insulin-stimulated glucose transport and of the intracellular immune response. To further elucidate the role of this cellular regulator in diet-induced obesity and insulin resistance, we generated both liver (PKC-Alb) and adipose tissue (PKC-Ap2) specific knockout mice. Body weight, fat mass, food intake, glucose homeostasis and energy expenditure were evaluated in mice maintained on either chow or high fat diet (HFD). Ablation of PKCλ from the adipose tissue resulted in mice that were indistinguishable from their wild-type littermates. However, PKC-Alb mice were resistant to diet-induced obesity (DIO). Surprisingly this DIO resistance was not associated with either a reduction in caloric intake or an increase in energy expenditure as compared with their wild-type littermates. Furthermore, these mice displayed an improvement in glucose tolerance. When maintained on chow diet, these mice were similar to wild types in respect to body weight and fat mass, yet insulin sensitivity was impaired compared with wt littermates. Taken together these data suggest that hepatic PKCλ is modulating insulin-mediated glucose turnover and response to high fat diet feeding, thus offering a deeper understanding of an important target for anti-obesity therapeutics.

Indexed as

atypical protein kinase C-lambdadiet induced obesityenergy expenditureglucose toleranceinsulin resistance

Identifiers

PMID23700535
PMCPMC3609106
OpenAlexW2017470792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.